GAO: GDUFA Approvals are Faster, but FDA Lacks Plan for Extra Fees

Generic Line
The FDA surpassed many of its performance goals for generic drug applications through 2016, but the agency needs a plan for the user fees collected but not spent in the same year, according to the GAO.

To View This Article:


Subscribe To Generic Line